ACP
GNVC

Acuta Capital Partners’s GenVec, Inc. GNVC Stock Holding History

Acuta Capital Partners’s Portfolio GNVC Stock Details GNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-15,451
Closed -$456K – 71
2015
Q1 		$456K Sell
15,451
-20,027
-56% -$658K 0.38% 44
2014
Q4 		$738K Buy
+35,478
New +$686K 0.5% 48

Other funds holding GNVC

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acuta Capital Partners's GNVC Position: Q2 2015 in Review

Acuta Capital Partners sold out of GenVec, Inc. (GNVC) in Q2 2015, closing a stake of 15,451 shares — an estimated $456K sold.

Acuta Capital Partners first reported a position in GNVC in Q4 2014 and held it in 2 quarters. The position peaked at $738K in Q4 2014. 28 funds tracked by Wall St. Rank hold GNVC as of Q2 2015.

  • Acuta Capital Partners reported no remaining GenVec, Inc. position as of Q2 2015 after selling out during the quarter.
  • Acuta Capital Partners sold 15,451 GenVec, Inc. shares in Q2 2015, an estimated $456K.
  • Acuta Capital Partners first reported a position in GenVec, Inc. in Q4 2014 and held it in 2 quarters.
  • Acuta Capital Partners's GenVec, Inc. position peaked at $738K in Q4 2014.
  • 28 funds tracked by Wall St. Rank held GenVec, Inc. as of Q2 2015.

Based on Acuta Capital Partners's 13F filing for Q2 2015, filed 14 Aug 2015.